The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

3D Cell Cultures: Products, Technologies and Key Application Areas (2nd Edition), 2017-2030

  • Lowest Price Guaranteed From USD 2,499

  • Published
    September 2017

  • Pages
    339

  • View Count
    1485

Example Insights

  1. Over 200 3D cell culture products are either commercially available or are under development; of these, ~60% use scaffold based while ~40% use scaffold free formats. Some products can be used as both scaffold based and scaffold free formats. Of the total number of 3D cell culture products, 40% are hydrogels / ECMs and 34% are 3D cultureware products. In addition to the aforementioned products, the 3D cell culture market includes several 3D bioreactors, which have emerged as important scaffold free systems to carry out large scale production. 
  2. The market is characterized by the presence of nearly 125 players; in addition to industry stalwarts, the landscape features participation of several small-sized and mid-sized firms. Examples of small-sized companies that offer 3D culture products include (in alphabetical order) 3D BioMatrix, Celartia, Cellec Biotek, EBERS, Global Cell Solutions, Nanofiber Solutions, Nano3D Biosciences, PBS Biotech and RealBio Technology. Some of the mid-sized players that are active in this area include (in alphabetical order) 4titude®, Koken, MatTek Corporation, STEMCELL Technologies and TAP Biosystems. Examples of the established players include (in alphabetical order) Corning Life Sciences, EMD Millipore, GE Healthcare, Sigma-Aldrich and Thermo Fisher Scientific.
  3. An analysis on the social media platform, Twitter, reveals an increasing volume of tweets related to the 3D cell cultures; between 2008 and 2016, a CAGR of 57% was registered in the number of tweets. In the given time period, over 4000 relevant tweets were recorded; this clearly indicates an upsurge in the popularity of the 3D cell culture approaches.
  4. Over 90% of the overall 3D cell culture market is focused on research. However, as the challenges (such as lack of awareness, constraints in scalability and inconsistencies in system optimization) associated with the application of these robust culture systems are addressed, these systems are expected to be extensively used for the development, manufacturing and characterization of pharmacological interventions.
  5. Our outlook is highly promising as we anticipate the use of 3D cell culture systems across different application areas over the coming decade. In fact, we predict the market to grow at an annualized rate of over 20% till 2030. From a regional perspective, North America (specifically the US) is likely to maintain its domination in the future.
  6. Cancer research and drug discovery, with over 50% share, currently account for a significant portion of the market. As the research pace heightens, the use of 3D cell cultures in stem cell research and tissue engineering / regenerative medicine, currently representing a sizeable share, is also likely to expand aggressively.

Overview

A number of research efforts in drug discovery are being directed towards the introduction of in vitro testing models that replicate the in vivo microenvironment and provide physiologically relevant insights. Cell culture monolayers or 2D cell cultures are known to harbor differences in morphology, growth rate, function, viability and the overall behavior, as compared to those in natural environment. However, it has been realized that 3D cell cultures facilitate cell interaction with the surrounding media in all the possible dimensions. Cells cultivated using 3D techniques provide an appropriate ecosystem for cells to grow and proliferate and, consequently generate more accurate results of the experiments conducted on them.

The 3D cell culture industry is currently characterized by presence of several scaffold-based and scaffold-free products and services, widely being used for the purpose of research across a variety of application areas. Examples of scaffold-based 3D culture products include solid scaffolds, hydrogels, ECM-coated plates and microcarriers. Products, such as hanging drop plates, ultra-low attachment surfaces, micropatterned plates and suspension culture systems (such as 3D bioreactors), are some of the important scaffold-free 3D technologies that are currently available. It is worth highlighting that despite the advantages that they offer, the adoption of 3D cell cultures is hindered by certain challenges. These cell culture systems are currently limited to small scale production of cells, thereby, restricting their use to research applications only. Moreover, 3D culture techniques still need to be optimized in order to ensure consistency of results generated across different scales of operation. Due to the aforementioned challenges, 2D cultures continue to be preferred over 3D culture systems; however, with increasing awareness of the advantages of 3D cultures, a significant proportion of researchers are anticipated to gradually transition towards 3D culture systems.

 

Scope of the Report

It is well-known that, of the several drug / therapy candidates undergoing clinical evaluation, very few make it to advanced stages and an even lesser number receive regulatory approval. One of the key reasons for the failure of therapeutic candidates in clinical trials is the use of conventional 2D cell culture systems in early research studies. It is important to reiterate that these 2D systems are severely limited in a number of aspects. For instance, only 50% of the cell surface is exposed to the culture media; as a result, the actual responses of cells to specific modulators / stimulants cannot be accurately understood. It is also worth noting that attrition rates of close to 95% have been reported for anti-cancer drug candidates as a result of inaccurate in vitro drug efficacy results and unforeseen toxicity issues that were not properly assessed due to the limitation of 2D culture models. The use of advanced 3D cell culture techniques in in vitro studies is seen to have the capability to overcome several such challenges, currently associated with 2D systems.

The ‘3D Cell Cultures: Products, Technologies and Key Application Areas (2nd Edition), 2017-2030’ report features an extensive study on the various scaffold-based and scaffold-free 3D culture systems. We identified over 80 hydrogel / ECM based products, 70 inserts / plates / other cultureware and 50 3D bioreactors that are widely being used for a variety of research applications across the globe. In addition, several kits, assays and tools are also available to carry out cytotoxicity assessments, transfections and cell viability testing. Amongst other elements, the report features:

  • An elaborate discussion on the methods used for fabrication of 3D scaffolds and matrices, highlighting the materials used, the process of fabrication, merits and demerits, and the applications of all of the methods.
  • An in-depth classification of 3D culture systems, which are categorized under scaffold-based systems (such as hydrogels / ECMs, solid scaffolds, micropatterned surfaces and microcarriers) and scaffold-free (such as hanging drop plates, suspension culture systems and organ-on-chips) 3D culture systems.
  • A review of the overall landscape of the 3D cell culture market with respect to scaffold-format (scaffold-based / scaffold-free), product type (Hydrogels / ECMs, 3D cultureware, 3D bioreactors), product sub-type (hydrogels / ECMs are further classified on the basis of source and 3D cultureware on the basis of solid scaffolds, suspension culture systems, microfluidic systems, ECM-coated plates, attachment resistant cell culture plates, micropatterned surfaces) and product availability across different regions of the world.
  • Comprehensive profiles of the key developers (with two or more unique bioreactors in their portfolio) of 3D bioreactors, featuring a brief company overview, description of the product, advantages, applications, collaborations related to the product, and a comprehensive future outlook. Additionally, the report includes profiles of companies with more than five unique 3D culture products (inserts or plates or hydrogels) in their portfolio and those that specialize in the field of organ-on-chips.
  • A social media analysis depicting the prevalent and emerging trends, and the popularity of 3D cell cultures on the social media platform, Twitter. The analysis was carried out using tweets posted on the platform from 2008 to 2017.
  • An insightful analysis, highlighting the applications of each of the 3D culture products mentioned in the market landscape. The applications have been categorized under [A] Cancer research, [B] Drug discovery and toxicity screening, [C] Stem cell research, [D] Tissue engineering / regenerative medicine. Additionally, the section represents the distribution of each of the product segments across the aforementioned applications, highlighting the relevance of different types of products in biomedical research.

One of the key objectives of the report was to estimate the future size of the global 3D cell culture market. We adopted a top-down approach to evaluate the likely success and the growth of the market over the next 10-15 years. The insights generated on the future opportunity are segmented on the basis of applications areas, key geographies (the US, EU, Asia and the rest of the world), product type, scaffold format (scaffold-based versus scaffold-free) and the end use (research versus therapeutics). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios for the period 2017-2030, namely conservative, base and optimistic scenarios, which represent three different tracks of the industry’s evolution.

The research, analysis and insights presented in this report are backed by a deep understanding of key insights gathered from both secondary and primary research. The report presents details of the conversations with (in alphabetical order of company name) Scott Brush (VP Sales and Marketing, BRTI Life Sciences), Jens Kelm (CSO, InSphero), Darlene Thieken (Project Manager, Nanofiber Solutions), Colin Sanctuary (Co-Founder and CEO, QGel), Bill Anderson (President / CEO, Synthecon), Anonymous (President and CEO, US based start-up), Anonymous (VP Technical, Business Operations & Co-Founder, US based company).

Contents

Chapter 2  presents an executive summary of the report. It offers a high-level view on where the 3D cell cultures market is headed in the mid to long term.

Chapter 3  provides a general introduction to 3D culture systems. In this section, we have briefly discussed the different types of cell cultures, the various methods of cell culturing and their application areas. The chapter features a comparative analysis of 2D and 3D cultures, and highlights the current need and advantages of 3D culture systems.

Chapter 4  gives an overview of the classification of 3D culture systems. It highlights the different 3D culture technologies, classified under scaffold-based and scaffold-free systems. It also highlights, in detail, the underlying concepts, advantages and disadvantages of each sub-category of 3D systems.

Chapter 5  presents summaries of the different techniques that are utilized to fabricate various 3D scaffolds and matrices. It provides information on the working principle, and merits and demerits associated with these methods. It also presents the key takeaways from various research studies that were carried out on matrices fabricated using the aforementioned methods.

Chapter 6  provides comprehensive lists of the different 3D culture systems that are available in the market or are under development. The section also presents analyses of the products on the basis of scaffold type, product type (3D hydrogels and ECMs / 3D cultureware / 3D bioreactors) and product sub-type. In addition, the chapter provides information on the geographical presence of the developers of these 3D culture systems and details on the companies that offer 3D culture related services and associated consumables.

Chapter 7  presents a detailed overview on the most popular application areas, which include cancer research, drug discovery and toxicity screening, stem cell research and tissue engineering / regenerative medicine. It features an elaborate analysis, highlighting the application area(s) for all the products mentioned in the market landscape (Chapter 6). Additionally, the section features an illustrative representation of the product type(s) that are most widely used for a particular application.

Chapter 8  provides insights on the popularity of 3D cell cultures on the social media platform, Twitter. The section highlights the yearly distribution of tweets posted on the platform in the time period 2008-2017, and the most significant events responsible for increase / decrease in the volume of tweets each year, during the above-mentioned time period. Additionally, the chapter showcases the most talked about 3D culture products and application areas on social media.

Chapter 9  provides detailed profiles of the players with over five unique products in their 3D culture portfolio (hydrogels / ECMs and 3D cultureware). Each profile includes information on the developer, its product portfolio, recent collaborations and a discussion on the future outlook of the company. Additionally, the chapter includes profiles of prominent developers of organ-on-chips.

Chapter 10  presents detailed profiles of key players with more than two unique 3D bioreactors in their portfolio. Each profile includes a brief overview of the developer, information on the product portfolio and a discussion on the future outlook of the company.

Chapter 11  presents a comprehensive market forecast, highlighting the future potential of the market till 2030. The chapter presents a detailed market segmentation on the basis of product type (3D bioreactors, hydrogels / ECM, solid scaffolds, microfluidic plates, suspension culture systems), scaffold type (scaffold-based versus scaffold-free) and end use (research versus therapeutics) that are likely to contribute to the market in the coming decade. Additionally, the section highlights the contribution of different geographies (the North America, EU, Asia and rest of the world) in the 3D culture market.

Chapter 12  presents insights from the survey conducted for this study. We invited close to 100 stakeholders involved in the development of 3D cell culture systems. The participants, who were primarily Founder / CXO / Senior Management level representatives of their respective companies, helped us develop a deeper understanding on the nature of their services and the associated commercial potential.

Chapter 13  summarizes the overall report. The chapter provides a list of the key takeaways and presents our independent opinion on the 3D cell cultures market, based on the research and analysis described in the previous chapters.

Chapter 14  is a collection of interview transcripts of the discussions held with key stakeholders in this market. In this chapter, we have presented the details of our conversations with ( in alphabetical order of company name ) Scott Brush (VP Sales and Marketing, BRTI Life Sciences), Jens Kelm (CSO, InSphero), Darlene Thieken (Project Manager, Nanofiber Solutions), Colin Sanctuary (Co-Founder and CEO, QGel), Bill Anderson (President / CEO, Synthecon), Anonymous (President and CEO, US based start-up), Anonymous (VP Technical, Business Operations & Co-Founder, US based company).

Chapter 15  is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 16  is an appendix, which provides the list of companies and organizations mentioned in the report.

Table of Contents

1 PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
 
2 EXECUTIVE SUMMARY
 
3 INTRODUCTION
3.1. Chapter Overview
3.2. Classification of Cell Cultures
3.2.1. Primary Cell Cultures
3.2.2. Cell Lines
3.3. Morphology of Cells in Culture
3.4. Transition from 2D to 3D Cell Culture
3.5. The Concept of 3D Cell Culture
3.5.1. Components of the Extra Cellular Matrix (ECM)
3.5.2. In Vitro Cell Culture
3.5.3. Selection of Culture Format
3.6. Cell Cultures: Establishment and Maintenance
3.6.1. Isolating Cells from Tissues
3.6.2. Maintaining Cells in Culture
3.6.3. Sub-Culturing
3.6.4. Cryogenic Storage
3.6.5. Cross-Contamination Concerns
3.7. The Need for 3D Cell Culture Systems
3.7.1. Model Systems
3.7.2. Drug Discovery and Preclinical Research
3.7.3. Cancer Research
3.7.4. Virology Research
3.7.5. Genetic Engineering and Gene Therapy Research
3.8. Cell Culturing: Basic Requirements
3.8.1. The Cell Culture Facility and Safety Guidelines
3.8.2. Avoiding Contamination
3.8.3. Cell Culture Health and Optimal Conditions
3.9. 3D Cell Culture: Advantages and Limitations
3.10. Future Landscape of 3D Cell Culture
 
4 CLASSIFICATION OF 3D CELL CULTURE SYSTEMS
4.1 3D Cell Culture Classification: An Overview
4.2. Scaffold Based 3D Cell Cultures
4.2.1. Hydrogels / Extra Cellular Matrix (ECM) Analogs
4.2.2. Solid Scaffolds
4.2.3. Micropatterned Surfaces
4.2.4. Microcarriers
4.3. Scaffold Free 3D Cell Cultures
4.3.1. Attachment Resistant Surfaces
4.3.2. Suspension Culture Systems
4.3.2.1. Hanging Drop Plates
4.3.2.2. 3D Bioreactors
4.3.2.3. Magnetic Levitation and 3D Bioprinting
4.3.3. Microfluidic Surfaces and Organs-on-Chips
4.4. Organoids
 
5 METHODS USED FOR FABRICATION OF 3D MATRICES AND SCAFFOLDS
5.1. Chapter Overview
5.2. Methods for Fabricating Porous Scaffolds
5.2.1. Particulate Leaching
5.2.2. Solvent Casting
5.2.3. Emulsion Templating
5.2.4. Gas Foaming
5.2.5. Melt Molding
5.2.6. Microsphere Sintering
5.3. Methods for Fabricating Fibrous Scaffolds
5.3.1. Electrospinning
5.3.2. Phase Separation
5.3.3. Self-Assembly
5.3.4. Fiber Mesh and Fiber Bonding
5.4. Methods for Fabricating Hydrogels
5.4.1. Gelation
5.4.2. Solvent Casting and Particulate Leaching
5.4.3. Gas Foaming
5.4.4. Freeze Drying
5.4.5. Co-Polymerization / Crosslinking
5.4.6. Microfluidics
5.5. Methods for Fabricating Custom Scaffolds
5.5.1. Stereo-lithography
5.5.2. 3D Bioprinting and Selective Laser Sintering (SLS)
5.5.3. Fused Deposition Modeling
5.5.4. Membrane Lamination
5.5.5. Rapid Prototyping / Solid Free-Form (SFF) Technique
5.6. Methods for Fabricating Microspheres
5.6.1. Solvent Evaporation
5.6.2. Single and Double Emulsification
5.6.3. Particle Aggregation
5.7. Methods for Fabricating Native Scaffolds
5.7.1. Decellularization
 
6 MARKET OVERVIEW
6.1. Chapter Overview
6.2. 3D Cell Culture Products: List of Hydrogels / Extracellular Matrices (ECMs), Cultureware and Bioreactors
6.2.1. 3D Cell Culture Products: Distribution by Type
6.2.2. 3D Cell Culture Products: Distribution by Scaffold Format
6.2.3. 3D Cell Culture Products: Distribution by Hydrogels / ECMs
6.2.4. 3D Cell Culture Products: Distribution by Cultureware
6.2.5. 3D Cell Culture Products: Most Active Players
6.2.6. 3D Cell Culture Products: Geographical Landscape of Developers
6.3. 3D Cell Culture Products: Assay Kits, Reagents and Services
 

7 3D CELL CULTURE: KEY APPLICATION AREAS
7.1. Chapter Overview
7.2. 3D Cell Culture Systems in Cancer Research
7.2.1. Reasons to Adopt 3D Cell Culture Systems in Cancer Research
7.2.2. Improving Cancer Drug Screening with 3D Cell Culture Systems
7.3. 3D Cell Culture Systems in Drug Discovery and Toxicity Screening
7.3.1. Drug Development Studies
7.3.2. Toxicity Screening
7.4. 3D Cell Culture Systems in Stem Cell Research
7.4.1. Potential of 3D Cell Culture Systems in Stem Cell Differentiation
7.4.2. In Vitro 3D Microenvironment to Induce Embryoid Body Formation
7.5. 3D Cell Culture Systems in Regenerative Medicine and Tissue Engineering
7. 6. 3D Cell Culture Systems: Analyses on Key Application Areas
7.6.1. 3D Cell Culture Products: Distribution by Applications and Types
7.6.1.1. Hydrogels / ECMs: Distribution by Applications
7.6.1.2. 3D Cultureware: Distribution by Applications
7.6.1.3. 3D Bioreactors: Distribution by Applications
 
8 EMERGING TRENDS IN 3D CELL CULTURE ON SOCIAL� MEDIA
8.1. Chapter Overview
8.2. 3D Cell Culture: Trends on Twitter
8.2.1. 3D Cell Culture: Yearly Distribution of Tweets
8.2.2. 3D Cell Culture: Word Cloud Analysis
8.2.3. 3D Cell Culture: Popular Product Types on Twitter, 2008-2017
8.2.4. 3D Cell Culture: Popular Product Sub-types on Twitter, 2008-2017
8.2.5. 3D Cell Culture: Popular Applications on Twitter, 2008-2017
 
9 3D CELL CULTURE PRODUCTS: KEY PLAYERS
9.1. Chapter Overview
9.2. Developers of 3D Cultureware and ECMs / Hydrogels
9.2.1. 3D Biotek
9.2.1.1. Developer Overview
9.2.1.2. Product Portfolio
9.2.1.3. Future Outlook
 
9.2.2. Advanced BioMatrix
9.2.2.1. Developer Overview
9.2.2.2. Product Portfolio
9.2.2.3. Future Outlook
9.2.3. Alphabioregen
9.2.3.1. Developer Overview
9.2.3.2. Product Portfolio
9.2.3.3. Future Outlook
 
9.2.4. Corning Life Sciences
9.2.4.1. Company Overview
9.2.4.2. Product Portfolio
9.2.4.3. Future Outlook
 
9.2.5. ReproCELL
9.2.5.1. Developer Overview
9.2.5.2. Product Portfolio
9.2.5.3. Future Outlook
 
9.3. Developers of Organs-on-Chips
9.3.1. CN Bio Innovations
9.3.1.1. Company Overview
9.3.1.2. Product Portfolio
 
9.3.2. Emulate
9.3.2.1. Company Overview
9.3.2.2. Product Portfolio
 
9.3.3. InSphero
9.3.3.1. Company Overview
9.3.3.2. Product Portfolio
 
9.3.4. MIMETAS
9.3.4.1. Company Overview
9.3.4.2. Product Portfolio
 
9.3.5. Nortis
9.3.5.1. Company Overview
9.3.5.2. Product Portfolio
9.3.6. TissUse
9.3.6.1. Company Overview
9.3.6.2. Product Portfolio
 
10 3D CULTURE BIOREACTORS: KEY PLAYERS
10.1. Chapter Overview
10.2.1 Celartia
10.2.1.1. Developer Overview
10.2.1.2. Product Portfolio
10.2.1.3. Future Outlook
 
10.2.2. Cell Culture Company
10.2.2.1. Developer Overview
10.2.2.2. Product Portfolio
10.2.2.3. Future Outlook
 
10.2.3. CESCO BioProducts
10.2.3.1. Developer Overview
10.2.3.2. Product Portfolio
10.2.3.3. Future Outlook
 
10.2.4. China Regenerative Medicine International
10.2.4.1. Company Overview
10.2.4.2. Product Portfolio
10.2.4.3. Future Outlook
 
10.2.5. EBERS
10.2.5.1. Developer Overview
10.2.5.2. Product Portfolio
10.2.5.3. Future Outlook
 
10.2.6. PBS Biotech
10.2.6.1. Developer Overview
10.2.6.2. Product Portfolio
10.2.6.3. Future Outlook
 
10.2.7. Synthecon
10.2.7.1. Developer Overview
10.2.7.2. Product Portfolio
10.2.7.3. Future Outlook
 
11 MARKET FORECAST
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. 3D Cell Culture Market Forecast, 2017-2030
11.3.1. 3D Cell Culture Market Forecast: Distribution by Application
11.3.2. 3D Cell Culture Market Forecast: Distribution by Scaffold Format
11.3.3. 3D Cell Culture Market Forecast: Distribution by Product Type
11.3.4. 3D Cell Culture Market Forecast: Distribution by Geography
11.3.5. 3D Cell Culture Market Forecast: Distribution by End Use
 
12 SURVEY ANALYSIS
12.1. Chapter Overview
12.2. Overview of Respondents
12.3. Focus Area of the Company
12.4. Category of Lead Product(s)
12.5. Nature of Matrices
12.6. Development Status of Lead Product(s)
12.7. Sources of 3D Cultured Cells
12.8. Applications of 3D Cell Culture Products
12.9. Likely Market Size
 
13 CONCLUSION
13.1. 3D Cell Cultures, With Inherent Advantages over 2D Cell Cultures, are Gradually Gaining Attention in the Research Industry
13.2. Most 3D Cell Cultures Require a Supporting Scaffold for Growth and Propagation; However, Scaffold Free Techniques are Available as Well
13.3. Such Advanced Culture Systems have Found Use in a Myriad of Application Areas
13.4. Despite the Ongoing Innovation, 3D Cell Cultures are Yet to Unveil Potential in Mainstream Therapeutics
13.5. Post Mitigation of Associated Challenges, The Market is Likely to Witness a Higher Adoption
13.6. Overall, the 3D Cell Culture Market is Likely to Emerge as a Multi-Billion Dollar Market in the Long Term
 
14 INTERVIEW TRANSCRIPTS
14.1. Chapter Overview
14.2. Bill Anderson, President and Chief Executive Officer, Synthecon
14.3. Colin Sanctuary, Co-Founder and Chief Executive Officer, QGel
14.4. Darlene Thieken, Senior Management, Nanofiber Solutions
14.5. Jens Kelm, Chief Scientific Officer, InSphero
14.6. Scott Brush, VP Sales and Marketing, BRTI Life Sciences
14.7. Anonymous, President and Chief Executive Officer, Leading Company in 3D Cell Culture Domain
14.8. Anonymous, VP-Technical, Business Operations & Co-Founder, Leading Company in 3D Cell Culture Domain
 
15 APPENDIX: TABULATED DATA
 
16 APPENDIX: LIST OF COMPANIES AND ORGANIZATIONS

List of Figuers

Figure 3.1 Classifications of Cell Cultures
Figure 3.2 Types of Cell Culture Systems
Figure 3.3 Key Components of Extra Cellular Matrix (ECM)
Figure 3.4 Factors Influencing the Choice of 3D Cell Culture Systems
Figure 3.5 Methods of Cell Isolation from Tissues
Figure 3.6 Methods of Cryogenic Storage
Figure 3.7 Applications of Cell Culturing
Figure 3.8 3D Spheroids Generated via 3D Cell Culture Systems
Figure 3.9 Cell Culture: Biosafety Levels
Figure 4.1 Classification of 3D Cell Culture Systems
Figure 4.2 Natural Components of Extracellular Matrix (ECM) for Fabrication of Scaffolds
Figure 4.3 Hydrogels: Advantages and Disadvantages
Figure 4.4 Microcarriers: Advantages
Figure 4.5 Techniques Used for Formation of Spheroids
Figure 4.6 Spinner Flask and Rotating Wall Bioreactors: Device Structure
Figure 6.1 3D Cell Culture Products: Distribution by Type
Figure 6.2 3D Cell Culture Products: Distribution by Scaffold Format
Figure 6.3 3D Cell Culture Products: Distribution by Hydrogels / ECMs 
Figure 6.4 3D Cell Culture Products: Distribution by Cultureware
Figure 6.5 3D Cell Culture Products: Most Active Players
Figure 6.6 3D Cell Culture Products: Geographical Landscape of Developers
Figure 7.1 3D Cell Culture: Key Applications
Figure 7.2 Reasons to Adopt 3D Cell Culture Systems in Cancer Research
Figure 7.3 3D Cell Culture Systems in Drug Discovery and Toxicity Screening
Figure 7.4 3D Cell Culture: Effect on Stem Cell Differentiation
Figure 7.5 Methods for Embryoid Body Formation
Figure 7.6 Tissue Engineering: Top-Down and Bottom-Up Approach
Figure 7.7 3D Cell Culture Products: Distribution by Applications and Types
Figure 7.8 Hydrogels / ECMs: Distribution by Applications and Sub-types
Figure 7.9 3D Cultureware: Distribution by Applications and Sub-types
Figure 7.10 3D Bioreactors: Distribution by Applications 
Figure 8.1 3D Cell Culture: Yearly Distribution of Tweets, 2008-2017
Figure 8.2 3D Cell Culture: Historical Trends by Twitter Volume, 2008-2017
Figure 8.3 3D Cell Culture: Popular Keywords on Twitter, 2008-2017
Figure 8.4 3D Cell Culture: Popular Product Types on Twitter, 2008-2017
Figure 8.5 3D Cell Culture: Popular Product Sub-types on Twitter, 2008-2017
Figure 8.6 3D Cell Culture: Popular Organ-on-Chip Models on Twitter, 2008-2017
Figure 8.7 3D Cell Culture: Popular Applications on Twitter, 2008-2017
Figure 9.1 ReproCELL: Types of Alvetex® 3D Cell Culture Products
Figure 10.1 PetakaG3™ Bioreactors: Design Description
Figure 10.2 Cell Culture Company Perfusion Bioreactors: Features
Figure 10.3 MagDrive and AirDrive Mechanisms
Figure 10.4 Rotary Cell Culture System (RCCS): Advantages
Figure 11.1 3D Cell Culture Market (2017-2030): Base Scenario (USD Billion)
Figure 11.2 3D Cell Culture Market (2017-2030): Distribution by Application (USD Billion)
Figure 11.3 3D Cell Culture Market: Share by Application, 2017, 2030 (%) 
Figure 11.4 3D Cell Culture Market: Share by Scaffold Format, 2017 (USD Billion)
Figure 11.5 3D Cell Culture Market: Share by Product Type, 2017 (%)
Figure 11.6 3D Cell Culture Market: Share by Geography, 2017, 2030 (%)
Figure 11.7 3D Cell Culture Market: Share by End Use, 2017, 2030 (%)
Figure 11.8 3D Cell Culture Market: Leading Players, 2017 (%)
Figure 12.1 Survey Analysis: Distribution by Type of Company
Figure 12.2 Survey Analysis: Distribution by Location of Respondents
Figure 12.3 Survey Analysis: Distribution by Seniority Level of Respondents
Figure 12.4 Survey Analysis: Distribution by Focus Area of the Company
Figure 12.5 Survey Analysis: Category of Lead Product(s)
Figure 12.6 Survey Analysis: Nature of Matrices
Figure 12.7 Survey Analysis: Status of Development of Lead Product(s)
Figure 12.8 Survey Analysis: Source of 3D Cultured Cells
Figure 12.9 Survey Analysis: Distribution by Application of 3D Cell Culture Products
Figure 12.10 Survey Analysis: Distribution by Likely Size of 3D Cell Culture Market
Figure 13.1 Overall 3D Cell Culture Market: Conservative, Base and Optimistic Scenarios, 2017-2030 (USD Billion)

List of Tables

Table 3.1 Morphology of Cells in a Culture
Table 3.2 Differences between 2D and 3D Cell Cultures
Table 3.3 Features of 3D Spheroids Generated via 3D Cell Culture Systems
Table 4.1 Scaffold Based and Scaffold Free Systems: Advantages and Disadvantages
Table 4.2 Natural and Synthetic Scaffolds: Advantages and Disadvantages
Table 4.3 Natural and Synthetic Hydrogels: Advantages and Disadvantages
Table 4.4 Cell Cultures Used in Magnetic Levitation
Table 4.6 Organoids: Origin and Culture Techniques
Table 5.1 Methods for Fabrication of Porous Scaffolds: Merits and Demerits
Table 5.2 3D Cell Culture Studies Using Porous Scaffolds
Table 5.3 Methods for Fabrication of Fibrous Scaffolds
Table 5.4 Methods for Fabrication of Fibrous Scaffolds: Merits and Demerits
Table 5.5 3D Cell Culture Studies Using Fibrous Scaffolds
Table 5.6 Methods for Fabrication of Hydrogels: Merits and Demerits
Table 5.7 3D Cell Culture Studies Using Hydrogels
Table 5.8 Fabrication of Custom Scaffolds: Merits and Demerits
Table 5.9 3D Cell Culture Studies Using Custom Scaffolds
Table 5.10 Fabrication of Microspheres: Merits and Demerits
Table 5.11 3D Cell Culture Studies Using Microspheres
Table 5.12 3D Cell Culture Studies Using Native Scaffolds
Table 6.1 3D Cell Culture Products: List of Hydrogels / ECM
Table 6.2 3D Cell Culture Products: List of Cultureware
Table 6.3 3D Cell Culture Products: List of Bioreactors
Table 6.4 3D Cell Culture Products: List of Assay Kits and Reagents
Table 6.5 3D Cell Culture Products: List of Services
Table 7.1 3D Cell Culture Products: Applications of Hydrogels / Extra Cellular Matrices (ECMs)
Table 7.2 3D Cell Culture Products: Applications of 3D Cultureware
Table 7.3 3D Cell Culture Products: Applications of 3D Bioreactors
Table 7.4 Hydrogels / ECM: Applications of Sub-types
Table 7.5 3D Cultureware: Applications of Sub-types
Table 7.6 3D Bioreactors: Applications
Table 9.1 3D Cell Cultureware and ECM: List of Players Profiled
Table 9.2 3D Biotek: Specifications of 3D Insert™-PS
Table 9.3 3D Biotek: Specifications of 3D Insert™-PCL
Table 9.4 Advanced BioMatrix: Specifications of PureCol® Collagen Coated T-25 Flasks
Table 9.5 Advanced BioMatrix: Specifications of PureCol® Collagen Coated Well Plates
Table 9.6 Advanced BioMatrix: Specifications of PureCol® Collagen Coated Dishes
Table 9.7 Advanced BioMatrix: Specifications of AlignCol®
Table 9.8 Advanced BioMatrix: Specifications of FibriCol®
Table 9.9 Advanced BioMatrix: Specifications of FlexiCol®
Table 9.10 Advanced BioMatrix: Specifications of Nutragen®
Table 9.11 Advanced BioMatrix: Specifications of PureCol®
Table 9.12 Advanced BioMatrix: Specifications of RatCol® Rat Tail Collagen I
Table 9.13 Advanced BioMatrix: Specifications of SphereCol®
Table 9.14 Advanced BioMatrix: Specifications of SpongeCol®
Table 9.15 Advanced BioMatrix: Specifications of TeloCol®
Table 9.16 Advanced BioMatrix: Specifications of VitroCol®
Table 9.17 Alphabioregen: Specifications of Hydrogel Coated Plates
Table 9.18 Alphabioregen: Specifications of Collagen Coated Plates
Table 9.19 Alphabioregen: Specifications of Matrix Coated Plates
Table 9.20 Alphabioregen: Specifications of Poly-L-Lysine Coated Plates
Table 9.21 Alphabioregen: Specifications of AlphaBioGel Products
Table 9.22 Alphabioregen: Specifications of Collagel Hydrogel Products
Table 9.23 Corning Life Sciences: Specifications of Corning® BioCoat™ Cultureware
Table 9.24 Corning Life Sciences: Specifications of Corning® CellBIND® Surface
Table 9.25 Corning Life Sciences: Specifications of Corning® Osteo Assay Surface Cultureware
Table 9.26 Corning Life Sciences: Specifications of Corning® Primaria™ Surface
Table 9.27 Corning Life Sciences: Specifications of Corning® PureCoat™ Cultureware
Table 9.28 Corning Life Sciences: Specifications of Corning® Spheroid Microplates
Table 9.29 Corning Life Sciences: Specifications of Permeable Supports
Table 9.30 Corning Life Sciences: Specifications of Corning® Collagen Products
Table 9.31 Corning Life Sciences: Specifications of Corning® Laminin Products
Table 9.32 Corning Life Sciences: Specifications of Corning® Matrigel Matrices
Table 9.33 Corning Life Sciences: Specifications of Other Extra Cellular Matrix Based Products
Table 9.34 ReproCELL: Specifications of Alvetex® Scaffold Multiwell Plate Formats
Table 9.35 ReproCELL: Specifications of Alvetex® Scaffold / Strata Well Insert
Table 9.36 ReproCELL: Specifications of Alvetex® Tools
Table 9.37 ReproCELL: Specifications of EZSPHERE® Products
Table 9.38 ReproCELL: Formats of EZSPHERE® Products
Table 9.39 ReproCELL: Specifications of Atelocollagen and Collagen Products
Table 10.1 3D Cell Culture Bioreactors: Companies Profiled
Table 10.2 Celartia: Features of PetakaG3™ Bioreactors
Table 10.3 Celartia: Specifications of PetakaG3™ ET Bioreactors
Table 10.4 Celartia: Specifications of PetakaG3™ HOT Bioreactors
Table 10.5 Cell Culture Company: Specifications of AutovaxID Bioreactor
Table 10.6 Cell Culture Company: Specifications of Maximizer Bioreactor
Table 10.7 Cell Culture Company: Specifications of MicroBrx Bioreactor
Table 10.8 Cell Culture Company: Specifications of Primer Bioreactor
Table 10.9 Cell Culture Company: Specifications of Xcellerator Bioreactor
Table 10.10 CESCO BioProducts: Specifications of BelloCell® Bioreactor
Table 10.11 EBERS: Specifications of TEB500 Series Bioreactor
Table 10.12 EBERS: Specifications of TEB1000 Series Bioreactor
Table 10.13 EBERS: Specifications of TC-3F Load Bioreactor
Table 10.14 PBS Biotech: Features of PBS Bioreactor Series with Dual Mechanism
Table 10.15 PBS Biotech: PBS MINI (PBS 0.1Mag / PBS 0.5Mag) Bioreactor
Table 10.16 PBS Biotech: Specifications of PBS 3 (PBS 3Air / PBS 3Mag) Bioreactor
Table 10.17 PBS Biotech: Specifications of PBS 15 (PBS 15Air / PBS 15Mag) Bioreactor
Table 10.18 PBS Biotech: Specifications of PBS 80 (PBS 80Air / PBS 80Mag) Bioreactor
Table 10.19 PBS Biotech: Specifications of PBS 500 Bioreactor
Table 10.20 Synthecon: Specifications of Autoclavable Bioreactors (RCCS-1)
Table 10.21 Synthecon: Specifications of Autoclavable Bioreactors (RCCS-4H / RCCS-4HD)
Table 10.22 Synthecon: Specifications of Perfusion Bioreactors (RCCMax / RCCMax Dual)
Table 10.23 Synthecon: Specifications of Single Use / Disposable Bioreactors (RCCS-D / RCCS-2D)
Table 10.24 Synthecon: Specifications of Single Use / Disposable Bioreactors (RCCS-4D / RCCS-4DQ)
Table 10.25 Synthecon: Specifications of Stem Cell Bioreactor (RCCS-1SC / RCCS-2SC)
Table 10.26 Synthecon: Specifications of Stem Cell Bioreactor (RCCS-4SC / RCCS- 4SCQ)
Table 12.1 Survey Response: Overview of the Participating Companies
Table 12.2 Survey Response: Overview of Respondents
Table 12.3 Survey Response: Focus Area of the Company
Table 12.4 Survey Response: Category of Lead Product(s)
Table 12.5 Survey Response: Nature of Matrices
Table 12.6 Survey Response: Development Status of Lead Product(s)
Table 12.7 Survey Response: Source of 3D Cultured Cells
Table 12.8 Survey Response: Applications of 3D Cell Culture Products
Table 12.9 Survey Response: Likely Size of 3D Cell Culture Market
Table 15.1 3D Cell Culture Products: Distribution by Type
Table 15.2 3D Cell Culture Products: Distribution by Scaffold Format
Table 15.3 3D Cell Culture Products: Distribution by Hydrogels / ECMs
Table 15.4 3D Cell Culture Products: Distribution by Cultureware
Table 15.5 3D Cell Culture Products: Most Active Players
Table 15.6 3D Cell Culture Products: Distribution by Applications and Types
Table 15.7 3D Cell Culture: Popular Product Types on Twitter, 2008-2017
Table 15.8 3D Cell Culture: Popular Organ-on-Chip Models on Twitter, 2008-2017
Table 15.9 3D Cell Culture Market (2017-2030): Base Scenario (USD Billion)
Table 15.10 3D Cell Culture Market (2017-2030): Optimistic Scenario (USD Billion)
Table 15.11 3D Cell Culture Market (2017-2030): Conservative Scenario (USD Billion)
Table 15.12 3D Cell Culture Market (2017-2030): Distribution by Application (USD Billion)
Table 15.13 3D Cell Culture Market: Share by Application, 2017, 2030 (%)
Table 15.14 3D Cell Culture Market: Share by Scaffold Format, 2017 (USD Billion)
Table 15.15 3D Cell Culture Market: Share by Product Type, 2017 (%)
Table 15.16 3D Cell Culture Market: Share by Geography, 2017, 2030 (%)
Table 15.17 3D Cell Culture Market: Share by End Use, 2017, 2030 (%)
Table 15.18 3D Cell Culture Market: Leading Players, 2017 (%)
Table 15.19 Survey Analysis: Distribution by Type of Company
Table 15.20 Survey Analysis: Distribution by Location of Respondents
Table 15.21 Survey Analysis: Distribution by Seniority Level of Respondents
Table 15.22 Survey Analysis: Distribution by Focus Area of the Company
Table 15.23 Survey Analysis: Category of Lead Product(s)
Table 15.24 Survey Analysis: Nature of Matrices
Table 15.25 Survey Analysis: Status of Development of Lead Product(s)
Table 15.26 Survey Analysis: Source of 3D Cultured Cells
Table 15.27 Survey Analysis: Distribution by Application of 3D Cell Culture Products
Table 15.28 Survey Analysis: Distribution by Likely Size of 3D Cell Culture Market
Table 15.29 Overall 3D Cell Culture Market: Conservative, Base and Optimistic Scenarios, 2017-2030 (USD Billion)

Listed Companies

The following companies and organizations have been mentioned in the report:

  1. 101Bio
  2. 3D Biomatrix
  3. 3D Biotek
  4. 4titude®
  5. AbbVie
  6. Accellta
  7. ACEA Biosciences
  8. Advanced BioMatrix
  9. AIM Biotech
  10. AK Biomedical
  11. Akron Biotech
  12. Alnylam Pharmaceuticals 
  13. Alphabioregen
  14. AMS Biotechnology 
  15. Antleron
  16. Applikon Biotechnology
  17. ARL Designs
  18. AstraZeneca 
  19. AUCTEQ Biosystems
  20. AvantiCell Science
  21. AxoSim
  22. Bangalore Integrated System Solutions Tissue Growth Technologies (BiSS TGT)
  23. BASF
  24. BD Biosciences
  25. BellBrook Labs 
  26. Benitec Biopharma
  27. Bio-Byblos Biomedical
  28. BioCellChallenge
  29. BioConnect 
  30. Biogelx
  31. Biomaterials
  32. BioMedical Tissues
  33. Biomerix
  34. Biomimiq
  35. Biopta
  36. Biotronix 
  37. Boston Institute of Biotechnology
  38. Bristol-Myers Squibb
  39. BRTI Life Sciences
  40. Celartia
  41. Celenys
  42. Cell Culture Company 
  43. Cellec Biotek
  44. Cellendes
  45. Cellevate
  46. CellSpring
  47. CellSystems
  48. CelVivo 
  49. CESCO BioProducts
  50. Cherry Biotech
  51. China Regenerative Medicine International
  52. China Stem Cell Clinical Applications Centre
  53. CN Bio Innovations 
  54. Corning Life Sciences 
  55. Cosmo Bio
  56. Covance
  57. Cyprotex
  58. CYTOO
  59. Dunn Labortechnik 
  60. Durham University
  61. East River BioSolutions
  62. EBERS
  63. Ectica Technologies
  64. EMD Millipore
  65. Emulate
  66. EPISKIN  
  67. Epithelix
  68. Eppendorf
  69. ESI BIO
  70. ETH Zurich
  71. Fennik Life Sciences
  72. FiberCell Systems
  73. Fraunhofer IGB
  74. Fraunhofer IWS
  75. FUJIFILM
  76. GE Healthcare
  77. GeneON 
  78. GlaxoSmithKline
  79. Global Cell Solutions
  80. Greiner Bio-One 
  81. HµREL® Corporation
  82. Hamilton Company
  83. HK International Regenerative Centre
  84. Hokkaido Soda 
  85. Humeltis
  86. Imperial College London
  87. InSphero
  88. Instron
  89. InvitroCue
  90. InvivoSciences
  91. Iris Biosciences
  92. Japan Vilene
  93. Johnson & Johnson
  94. J-TEC
  95. KU Leuven
  96. Kirkstall
  97. KIYATEC
  98. Koken 
  99. Kollodis BioSciences
  100. Kuraray 
  101. LAMBDA Laboratory Instruments
  102. Leibniz Research Centre for Working Environment and Human Factors 
  103. Lena Biosciences
  104. LFB Biomanufacturing
  105. Life Technologies
  106. Lifecore Biomedical
  107. Linari Engineering
  108. Locate Therapeutics
  109. Lonza
  110. LuoLabs
  111. Massachusetts Institute of Technology
  112. MatTek 
  113. MBL International
  114. MD Biosciences
  115. Menicon Life Science
  116. Merck
  117. MicroTissues
  118. MIMETAS
  119. Mirus Bio 
  120. MRC Centre for Drug Safety Science 
  121. Nano3D Biosciences
  122. Nanofiber Solutions
  123. Nanogaia
  124. National Cancer Institute
  125. NC3Rs
  126. Neuromics
  127. Nortis
  128. Novadip
  129. ORGANOGENIX
  130. Organovo 
  131. PBS Biotech
  132. PELOBiotech
  133. PepGel
  134. Percell Biolytica
  135. Pfizer
  136. Pishon Biomedical
  137. Pluristem Therapeutics
  138. ProBioGen
  139. Promega
  140. ProSys
  141. Protista 
  142. QGel Bio
  143. Quinxell Technologies
  144. Radboudumc 
  145. RealBio Technology
  146. RegeneMed
  147. Reinnervate
  148. ReproCELL
  149. Roche
  150. Sanofi
  151. Sarstedt
  152. Sartorius Stedim Biotech
  153. SCIVAX Life Sciences
  154. Seres Therapeutics
  155. Sigma-Aldrich
  156. SKE Research Equipment
  157. SkinAxis
  158. SoloHill Engineering
  159. SpheriTech
  160. StemCell Systems
  161. STEMCELL Technologies
  162. Stemmatters 
  163. Stratatech
  164. StratiCELL
  165. Sumitomo Bakelite
  166. SUN Bioscience
  167. Synthecon
  168. SynVivo
  169. TAP Biosystems
  170. TARA Biosystems
  171. The Well Bioscience
  172. Thermo Fisher Scientific
  173. Tianjin Weikai Bioeng
  174. TissueClick
  175. TissUse
  176. Trevigen
  177. TU Berlin
  178. TU Dortmund
  179. UB-Care
  180. Univalor
  181. University College London
  182. University of Liverpool
  183. University of Oxford
  184. University of Pittsburgh 
  185. University of Zaragoza
  186. University of Zurich
  187. University of Würzburg
  188. UPM Biochemicals
  189. Utrecht University 
  190. Viscofan BioEngineering
  191. Vivo Biosciences
  192. Wyss Institute at Harvard University
     

Request Customization

Please select a suitable option for customization in the report

PRICING DETAILS

USD 2,499

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site / office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com